147 related articles for article (PubMed ID: 30538856)
1. The Analysis of Correlative Factors of Visual Acuity with Intravitreal Conbercept Injection in Macular Edema Associated with Branch Retinal Vein Occlusion.
Luo W; Jia F; Liu M; Wang Y; Zhang T
J Ophthalmol; 2018; 2018():7348153. PubMed ID: 30538856
[TBL] [Abstract][Full Text] [Related]
2. Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept.
Zhang Q; Hou Y; Cao X; Zhang R; Liu Y; Wei C; Wu C; Mei L; Zhang P
BMC Ophthalmol; 2021 Nov; 21(1):402. PubMed ID: 34809591
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of foveal photoreceptor layer in eyes with macular edema associated with branch retinal vein occlusion after ozurdex treatment.
Altunel O; Duru N; Goktas A; Ozkose A; Goktas E; Atas M
Int Ophthalmol; 2017 Apr; 37(2):333-339. PubMed ID: 27221365
[TBL] [Abstract][Full Text] [Related]
4. OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.
Tang F; Qin X; Lu J; Song P; Li M; Ma X
Retina; 2020 Apr; 40(4):773-785. PubMed ID: 30640282
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal conbercept for branch retinal vein occlusion induced macular edema: one initial injection versus three monthly injections.
Chen X; Hu TM; Zuo J; Wu H; Liu ZH; Zhan YX; Xia Y; Wang J; Wei W
BMC Ophthalmol; 2020 Jun; 20(1):225. PubMed ID: 32527234
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intravitreal conbercept injection on short- and long-term macular edema in branch retinal vein occlusion.
Bai JY; Wang WY; Dou ZZ; Geng BC; Xu XY; Zhu YZ; Zhao SY; Liu M; Jia SY; Luo WJ
Int J Ophthalmol; 2022; 15(3):489-494. PubMed ID: 35310055
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Conbercept with Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion.
Li F; Sun M; Guo J; Ma A; Zhao B
Curr Eye Res; 2017 Aug; 42(8):1174-1178. PubMed ID: 28441077
[TBL] [Abstract][Full Text] [Related]
8. One-year efficacy of intravitreal conbercept injection for macular oedema secondary to central retinal vein occlusion in Chinese patients.
Zeng HY; Liu Q; Li XX; Sun YX; Zhang ZJ
Eye (Lond); 2020 Aug; 34(8):1459-1464. PubMed ID: 32094473
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
Jaissle GB; Szurman P; Feltgen N; Spitzer B; Pielen A; Rehak M; Spital G; Heimann H; Meyer CH;
Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):183-92. PubMed ID: 21337042
[TBL] [Abstract][Full Text] [Related]
10. Effect of Conbercept Treatment on Macular Edema and Microvascular Structure in Eyes with Retinal Vein Occlusions.
Ding X; Wang Y; Zou B; Zang D; Hao Y
Int J Gen Med; 2022; 15():7311-7318. PubMed ID: 36133911
[TBL] [Abstract][Full Text] [Related]
11. Short-term effect of intravitreal conbercept injection on major and macular branch retinal vein occlusion.
Tao Y; Huang C; Liu M; Sun L; Li L; Wei Y; Yu X; Wang H
J Int Med Res; 2019 Mar; 47(3):1202-1209. PubMed ID: 30678515
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
Kim M; Jeong S; Sagong M
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
[TBL] [Abstract][Full Text] [Related]
13. Three Monthly Injections Versus One Initial Injection of Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion: 12-Month Results of a Prospective Randomized Study.
Tang W; Guo J; Xu G; Liu W; Chang Q
Ophthalmol Ther; 2022 Dec; 11(6):2309-2320. PubMed ID: 36223056
[TBL] [Abstract][Full Text] [Related]
14. Comparison of intravitreal bevacizumab and dexamethasone implant for the treatment of macula oedema associated with branch retinal vein occlusion.
Kim M; Lee DH; Byeon SH; Koh HJ; Kim SS; Lee SC
Br J Ophthalmol; 2015 Sep; 99(9):1271-6. PubMed ID: 25777815
[TBL] [Abstract][Full Text] [Related]
15. Conbercept improves macular microcirculation and retinal blood supply in the treatment of nonischemic branch retinal vein occlusion macular edema.
Huang Y; Linghu M; Hu W; Huang X
J Clin Lab Anal; 2022 Dec; 36(12):e24774. PubMed ID: 36408725
[TBL] [Abstract][Full Text] [Related]
16. Optical coherence tomography findings as a predictor of clinical course in patients with branch retinal vein occlusion treated with ranibizumab.
Shiono A; Kogo J; Sasaki H; Yomoda R; Jujo T; Tokuda N; Kitaoka Y; Takagi H
PLoS One; 2018; 13(6):e0199552. PubMed ID: 29924853
[TBL] [Abstract][Full Text] [Related]
17. Twenty-Four Month Results of Intravitreal Ranibizumab for Macular Edema after Branch Retinal Vein Occlusion: Visual Outcomes and Resolution of Macular Edema.
Inagaki M; Hirano Y; Yasuda Y; Kawamura M; Suzuki N; Yasukawa T; Yoshida M; Ogura Y
Semin Ophthalmol; 2021 Oct; 36(7):482-489. PubMed ID: 33617388
[No Abstract] [Full Text] [Related]
18. Results of the first 12 months treatment of macular edema complicating BRVO in patients treated with ranibizumab.
Lalinská L; Krásný J; Studený P; Veith M
Cesk Slov Oftalmol; 2018; 74(2):62-67. PubMed ID: 30441951
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
[No Abstract] [Full Text] [Related]
20. Optical coherence tomography angiography for macular microvessels in ischemic branch retinal vein occlusion treated with conbercept: predictive factors for the prognosis.
Tang L; Sun GL; Zhao Y; Yang TT; Yao J
Int J Ophthalmol; 2023; 16(12):2049-2055. PubMed ID: 38111937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
